Softwr

Healthcare · head to head

Epocrates vs Signant Health

Epocrates logo

Epocrates

Healthcare

Mobile clinical reference and decision support app

From
Free
Rated
-
Signant Health logo

Signant Health

Healthcare

eCOA-first clinical trial platform that has grown outward into EDC, eConsent and televisits

From
On request
Rated
-

The short version

  • Only Epocrates has a free tier, so it costs nothing to try first.
  • Each has a real cost: Epocrates pricing page not publicly accessible; Signant Health no pricing is published, and the software licence is a minority of the real bill once instrument licensing, translations, device provisioning and services are added, so early budget estimates are routinely too low.
  • They diverge on capability: Epocrates covers Drug Reference, Signant Health covers eCOA and ePRO.
  • Prices and features above were last checked on 31 August 2026.

Where they differ

Only the attributes on which Epocrates and Signant Health actually diverge.

Attributes where Epocrates and Signant Health differ
AttributeEpocratesSignant Health
Starting priceFreeOn request
Pricing modelfreemiumquote
Free tierYesNo
PlatformsMobileWeb, iOS, Android
Founded2000Unknown

Identical on both: user rating (Not yet rated), category (Healthcare).

What each one covers

Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.

Only in Epocrates

  • Drug Reference
  • Interactions
  • Dosing Calculators
  • Disease Information
  • Medical Procedures
  • Patient Education
  • EHR Systems
  • HIPAA

Only in Signant Health

  • eCOA and ePRO
  • Unified platform
  • eConsent
  • Randomisation and supplies
  • TeleVisits
  • Rater training
  • Data surveillance
  • Instrument library

What people use each for

The jobs each tool is most often brought in to do.

Epocrates

  • Patient Carenot Signant Health
  • Medical Recordsnot Signant Health
  • Practice Managementnot Signant Health
  • Telehealthnot Signant Health

Signant Health

  • A central nervous system or psychiatry trial where the primary endpoint is a rated scale and rater consistency decides the readoutnot Epocrates
  • A global study needing an outcome instrument translated and linguistically validated across a dozen languagesnot Epocrates
  • A decentralised or hybrid protocol combining televisits, eConsent and at-home patient reported outcomesnot Epocrates
  • A sponsor consolidating separate eCOA, eConsent and randomisation vendors onto one platform to cut reconciliation worknot Epocrates

Where each one falls short

Documented limitations, not opinions. Every one is a constraint you would hit in normal use.

Epocrates

  • Pricing page not publicly accessible

Signant Health

  • No pricing is published, and the software licence is a minority of the real bill once instrument licensing, translations, device provisioning and services are added, so early budget estimates are routinely too low.
  • Linguistic validation is charged per instrument per language and is on the critical path to first patient in, so adding a country late in start-up produces both a cost and a schedule hit.
  • Provisioned participant devices bring logistics, replacement, shipping and cellular connectivity obligations that persist for the life of the trial and are frequently underestimated.
  • The EDC component is newer than the eCOA heritage, so sponsors with complex data management requirements often keep an incumbent EDC and lose the single-database benefit that justifies the platform.
  • It is priced and scoped for sponsor-grade trials, which makes it a poor fit for investigator-initiated or academic studies that need outcome collection without the services layer.

Pricing, plan by plan

Epocrates

Free
  • FreeFree
    • Drug references
    • Calculators
    • Interactions
  • Premium$99/year
    • Enhanced content
    • Offline access

Signant Health

On request
  • SmartSignals Unified Platform$undefined/year
    • Priced per study through a sales process
    • Modules selected per protocol: EDC, eCOA, randomisation, eConsent, TeleVisits
    • Instrument licensing paid to scale owners on top of platform cost

Which should you pick?

Choose Epocrates if

  • You need drug reference.
  • You want to start without paying.
  • You work on Mobile.
  • You also want interactions.

Choose Signant Health if

  • You need ecoa and epro.
  • You work on Web, iOS, Android.
  • You also want unified platform.

Questions people ask

Is Epocrates or Signant Health better?
Neither clearly leads. Epocrates starts at Free and Signant Health at On request, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
Which is cheaper, Epocrates or Signant Health?
Epocrates has a free tier; the other does not. Paid plans start at Free for Epocrates and On request for Signant Health.
Does Epocrates or Signant Health run on more platforms?
Epocrates runs on Mobile. Signant Health runs on Web, iOS, Android.
Can I use Epocrates for free?
Yes. Epocrates has a free tier, so you can try it without paying. Signant Health starts at On request.
What is Epocrates best used for?
Epocrates is most often used for patient care, medical records, practice management, telehealth. Of those, patient care and medical records are not what Signant Health is typically brought in for.
What can Epocrates do that Signant Health cannot?
Epocrates covers Drug Reference, Interactions, Dosing Calculators, Disease Information. Signant Health covers eCOA and ePRO, Unified platform, eConsent, Randomisation and supplies.

Answered from the vendors’ own pages

Epocrates: How much does Epocrates cost?

Epocrates pricing information is not available to public access. Users must authenticate or contact the vendor to view pricing details.

Source
Signant Health: What is Signant best at?

Electronic clinical outcome assessment, particularly rated scales in central nervous system and psychiatry trials, together with rater training and endpoint quality services.

Signant Health: Is pricing published?

No. Everything is quoted per study, and instrument licences, translations and devices sit on top of the platform cost.

Signant Health: Can I use it only for eCOA?

Yes. The modules are selected per protocol, and many sponsors take eCOA and eConsent while keeping an existing EDC.

Signant Health: What drives the timeline?

Translation and linguistic validation of outcome instruments, which is per language per instrument and sits on the critical path to study start.

Share

Related pages

Other head to heads